Celadon Pharmaceuticals Plc – LSE:CEL.L

Celadon Pharmaceuticals stock price today

GBP 80.5
+65.1
+422.73%
Financial Health
0
1
2
3
4
5
6
7
8
9

Celadon Pharmaceuticals stock price monthly change

-74.12%
month

Celadon Pharmaceuticals stock price quarterly change

-74.12%
quarter

Celadon Pharmaceuticals stock price yearly change

-86.61%
year

Celadon Pharmaceuticals key metrics

Market Cap
12.30M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-0.17
Revenue
112.5K
EBITDA
-8.59M
Income
-10.71M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
-7641.78%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Celadon Pharmaceuticals stock price history

Celadon Pharmaceuticals stock forecast

Celadon Pharmaceuticals financial statements

Celadon Pharmaceuticals Plc (LSE:CEL.L): Profit margin
Mar 2023 4K -2.15M -53762.5%
Jun 2023 8K -4.30M -53762.5%
Sep 2023 33.5K -1.41M -4237.31%
Dec 2023 67K -2.83M -4237.31%
Celadon Pharmaceuticals Plc (LSE:CEL.L): Debt to assets
Mar 2023 9460000 6.42M 67.93%
Jun 2023 9460000 6.42M 67.93%
Sep 2023 9221000 6.04M 65.5%
Dec 2023 9221000 6.04M 65.5%
Celadon Pharmaceuticals Plc (LSE:CEL.L): Cash Flow
Mar 2023 -1.49M -104K -124K
Jun 2023 -2.97M -208K -264K
Sep 2023 -1.48M -66.5K 1.37M
Dec 2023 -2.96M -133K 2.74M

Celadon Pharmaceuticals alternative data

Celadon Pharmaceuticals Plc (LSE:CEL.L): Employee count
Aug 2023 24
Sep 2023 24
Oct 2023 24
Nov 2023 24
Dec 2023 24
Jan 2024 24
Feb 2024 24
Mar 2024 24
Apr 2024 24
May 2024 24
Jun 2024 24
Jul 2024 27

Celadon Pharmaceuticals other data

  • What's the price of Celadon Pharmaceuticals stock today?

    One share of Celadon Pharmaceuticals stock can currently be purchased for approximately $80.5.

  • When is Celadon Pharmaceuticals's next earnings date?

    Unfortunately, Celadon Pharmaceuticals's (CEL.L) next earnings date is currently unknown.

  • Does Celadon Pharmaceuticals pay dividends?

    No, Celadon Pharmaceuticals does not pay dividends.

  • How much money does Celadon Pharmaceuticals make?

    Celadon Pharmaceuticals has a market capitalization of 12.30M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 212.5% to 75K US dollars.

  • What is Celadon Pharmaceuticals's stock symbol?

    Celadon Pharmaceuticals Plc is traded on the LSE under the ticker symbol "CEL.L".

  • What is Celadon Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Celadon Pharmaceuticals?

    Shares of Celadon Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Celadon Pharmaceuticals have?

    As Jul 2024, Celadon Pharmaceuticals employs 27 workers, which is 13% more then previous month and 13% more then previous quarter.

  • When Celadon Pharmaceuticals went public?

    Celadon Pharmaceuticals Plc is publicly traded company for more then 3 years since IPO on 31 Mar 2022.

  • What is Celadon Pharmaceuticals's official website?

    The official website for Celadon Pharmaceuticals is celadonpharma.co.uk.

  • How can i contact Celadon Pharmaceuticals?

    Celadon Pharmaceuticals can be reached via phone at +44 20 3150 0252.

Celadon Pharmaceuticals company profile:

Celadon Pharmaceuticals Plc

celadonpharma.co.uk
Exchange:

LSE

Full time employees:

27

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom.

32-33 Cowcross Street
London, EC1M 6DF

:
ISIN: GB00BDQYGP38
: